Gustave Roussy Institute

from Wikipedia, the free encyclopedia
Institute logo

The Institut Gustave Roussy (IGR) is a French, non-profit institute for the research and treatment of cancer. The institute is based in Villejuif near Paris.

history

In 1921, the pathologist and rector of the Académie de Paris Gustave Roussy (1874-1948) founded the Hôpital Paul-Brousse in Villejuif specifically for the treatment of cancer. On November 14, 1925, the Conseil général de la Seine decreed the establishment of a regional cancer center for the Paris area ( Center régional de lutte contre le cancer de la banlieue parisienne ) and Professor Roussy was appointed first director on November 17. By a further decree of May 12, 1926, the regional cancer center in Villejuif was transformed into an institute for cancer research of the Faculty of Medicine in Paris ( Institut du Cancer de la Faculté de Médecine de Paris ). The institute was initially divided into a research unit ( Institut du Cancer ) with an attached hospital ( Section hospitalière ). On November 6, 1927, it received non-profit status. The institution was sponsored by the newly created Fondation pour le Développement de l'Institut du Cancer de la Faculté de Paris (“Foundation for the Development of the Cancer Research Institute of the Faculty of Paris”). On March 17, 1930, a new Section des laboratoires (research laboratory area) was opened by the President of the Republic Gaston Doumergue .

  • Pictures from 1934

  • Entrance gate

  • operating room

  • Address by G. Roussy

  • President Lebrun (left) and G. Roussy (center)

After the death of the institute's founder, Roussy, René Huguenin was appointed director of the Institut du cancer and Charles Oberling was appointed head of the laboratory division in 1949. In 1950 the institute was officially renamed Institut Gustave Roussy . In the following years, research at the institute focused on various areas, including: a. Pediatric oncology (on the initiative of Odile Schweisguth ) and treatment with radioisotopes ( Maurice Tubiana was the leader ). In the 1950s the institute was continuously expanded. Animal testing facilities as well as departments for radiation therapy, epidemiology, cell culture, virology and pharmacology were added. In 1976 the foundations were laid for a new hospital complex that went into operation in April 1980. Further extensions (magnetic resonance imaging, patient building, research pavilions) were made in the 1970s to 1990s.

Directors of the IGR

So far the following directors have held office:

Self-image ("mission") of the institute

The IGR sees itself as a center of excellence and innovation in cancer research. The aim of the research is to improve treatment and to gain a deeper understanding of the fundamentals of cancer development. For this purpose, biomedical basic research is carried out on the one hand, and clinical studies are carried out on the other hand to test new forms of treatment and drugs. Practically all modern treatment modalities of cancer treatment are available on site, from surgery, to diagnostic and interventional radiology and radiation therapy, to modern laboratory diagnostics and internal oncology. In addition, the IGR has a training function and, in cooperation with the University of Paris-South, runs an École de Cancérologie for further training of oncologists. There are numerous scientific collaborations, including a. with the German Cancer Research Center in Heidelberg , the Nederlands Kanker Instituut in Amsterdam , the MD Anderson Cancer Center in Houston and the Karolinska Institutet near Stockholm .

Web links

Individual evidence

  1. ↑ a b Histoire de l'Institut. Institute website, accessed on October 19, 2019 (French).
  2. ^ Les dates-clés de Gustave Roussy. Institute website, accessed on October 19, 2019 (French).
  3. ↑ L'Institut. Institute website, accessed on October 19, 2019 (French).
  4. ↑ Partenariats. Institute website, accessed on October 19, 2019 (French).

Coordinates: 48 ° 47 '40.1 "  N , 2 ° 20' 52.2"  E